Clinical Trial Update: Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Ointment in Patients With Psoriasis Vulgaris [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of a calcipotriol plus betamethasone dipropionate ointment in psoriasis vulgaris has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Calcipotriol plus Betamethasone Dipropionate Ointment (calcipotriene and betamethasone dipropionate ointment)

Snippet

Sponsor: LEO Pharma | Conditions: Psoriasis Vulgaris | Phase 4 | Status: COMPLETED